ImmPACT Bio USA Revenue and Competitors
Estimated Revenue & Valuation
- ImmPACT Bio USA's estimated annual revenue is currently $12.3M per year.
- ImmPACT Bio USA's estimated revenue per employee is $140,000
Employee Data
- ImmPACT Bio USA has 88 Employees.
- ImmPACT Bio USA grew their employee count by -19% last year.
ImmPACT Bio USA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | President and CFO | Reveal Email/Phone |
3 | Sr. Director, Program Management | Reveal Email/Phone |
4 | General Manager IL | Reveal Email/Phone |
5 | Group Head, Research | Reveal Email/Phone |
What Is ImmPACT Bio USA?
ImmPACT-Bio is pioneering a novel strategy to surmount a major challenge compromising current Chimeric Antigen Receptor T-cell (CAR-T) therapy. Our technology addresses the need to differentiate cancerous from non-cancerous tissues impacting the safety of the treatment which is to date a major limitation in reaching effectiveness. The company’s technology is based on the work of Prof. Gideon Gross (MIGAL – Galilee Research Institute), who is one of the pioneers of the world’s first CAR-T construct.
keywords:N/A
N/A
Total Funding
88
Number of Employees
$12.3M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Los Angeles
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.5M | 88 | -8% | N/A |
#2 | $7.5M | 88 | 5% | N/A |
#3 | $26.4M | 88 | 9% | N/A |
#4 | $23.8M | 88 | 14% | N/A |
#5 | $13.2M | 88 | 0% | $95M |